Posted by Michael Wonder on 07 Aug 2023
GP leaders advise practices not to prescribe cholesterol lowering drug inclisiran
1 August 2023 - Local GP leaders across the south of England have told practices not to follow the NHS’s advice to prescribe the cholesterol lowering drug inclisiran because of concerns over funding and long term safety monitoring.
The pushback comes amid a drive by NHS England, which published funding guidance in April 2023, and local integrated care boards to make the drug available in primary care to help tackle cardiovascular disease.
